ORIGINAL ARTICLES IN JOURNALS

Publications by Dr. Alexander Shifrin

Dr. Shifrin has published research on thyroid cancer and nodules, parathyroid disease, adrenal tumors, hereditary endocrine syndromes (RET mutation and MEN 2), pancreatic surgery and gene therapy. Click PDF or Article to open a paper.

Original papersLettersVideoBrochureAbstractsBookCited in guidelines

Original peer-reviewed papers (22)

  • 2000Auricchio A, Gao GP, Zoltick P, Shifrin A, Raper SE, Rivera V, Wilson JM. “Regulated insulin gene delivery for treatment of type I diabetes” Molecular Therapy, 1(5): S293; 2000 PDF
  • 2001A. Shifrin, A. Auricchio, Q-C. Yu, J. Wilson, S. Raper. "Adenoviral Vector-Mediated Insulin Gene Transfer in the Mouse Pancreas Corrects Streptozotocin-Induced Hyperglycemia" Gene Therapy, 2001, Oct 8 (19): 1480-9. PDF
  • 2005A. Shifrin, N. Chirmule, GP Gao, JM Wilson, S. Raper. "Innate Immune Response to Adenoviral Vector-Mediated Acute Pancreatitis". Pancreas, 2005 Mar;30(2):122-9. PDF
  • 2005A. Shifrin, N. Chirmule, Ph.D. Y. Zhang, S. Raper. “Macrophage ablation attenuates adenoviral vector-induced pancreatitis.” Surgery, 2005 May;137(5):545-51 PDF
  • 2006Mittendorf EA, Shifrin AL, Inabnet WB, Libutti SK, McHenry CR, Demeure MJ. “Islet Cell Tumors”. Journal chapter by Shifrin AL and Inabnet WB “Surgical Approaches to Islet Cell Tumors of the Pancreas.” Current Problems in Surgery, 2006 Oct;43(10):685-765. Review PDF
  • 2008Menon C, Bauer TW, Kelley ST, Raz DJ, Bleier JI, Patel K, Steele K, Prabakaran I, Shifrin A, Buerk DG, Sehgal CM, Fraker DL. “Tumoricidal activity of high-dose tumor necrosis factor-alpha is mediated by macrophage-derived nitric oxide burst and permanent blood flow shutdown.” Int J Cancer, 2008 Jul 15;123(2):464-75. PDF
  • 2007Strong VE, Shifrin AL, Inabnet WB. “Rapid Intraoperative Insulin Assay: Novel Method to Differentiate Insulinoma from Nesidioblastosis in the Pediatric Patient”. Annals of Surgical Innovation and Research, 2007 Oct 24;1(1):6 PDF
  • 2008Inabnet WB, Shifrin AL, Ahmed L, Sinha P. “Safety of same-day discharge in patients undergoing sutureless thyroidectomy: a comparison of local and general anesthesia.” Thyroid, 2008 Jan; 18(1): 57-61. PDF
  • 2008A. Shifrin, J. Vernick. “A thyroglossal duct cyst presenting as a thyroid nodule in the lateral neck.” Thyroid, 2008 Feb; 18(2) 263-5. PDF
  • 2009A. Harari, J. Allendorf, A. Shifrin, M. DiGorgi, and W. Inabnet, “Negative preoperative localization leads to greater resource utilization in the era of minimally invasive parathyroidectomy.” American Journal of Surgery, 2009 Jun;197(6): 769-73. PDF
  • 2009Shifrin, AL, Xenachis, C, Fay, A, Matulewicz, T, Y.-H. Kuo, Vernick, JJ. “One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, a rare primary hyperparathyroidism, and no pheochromocytomas: Is this a new syndrome-MEN 2C?” Surgery, 2009, Dec 146(6):998-1005 PDF
  • 2010Shifrin, AL, Ogilvie J, Stang, M, Xenachis, C., Fay, A., Matulewicz, T., Y.-H. Kuo, Vernick, JJ. “Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in two large, non-related families with the RET V804M proto-oncogene mutation”. Surgery, 2010 Dec;148(6):1274-81. PDF
  • 2011Shifrin AL, Zheng M, Vernick, J “Ectopic Adrenocortical Adenoma.” World Journal of Endocrine Surgery, January-April 2011;3(1) 45-6. PDF
  • 2013A. Shifrin, V. LiVolsi, M. Zheng, D. Lann, S. Fomin, E. Naylor, P. Mencel, A. Fay, B. Erler, T. Matulewicz. “Neuroendocrine thymic carcinoma metastatic to the parathyroid gland that was reimplanted into the forearm in a patient with multiple endocrine neoplasia type 1 syndrome: a challenging management dilemma”. Endocrine Practice, Vol 19, No. 6 November/December 2013, pp e1-e5. PDF
  • 2015A. Shifrin, M. Zheng, S. Jurewicz, J. Vernick, “Patient with Tracheal Duplication Cyst Clinically Misdiagnosed as a Thyroid Nodule” J Clin Endocrinol Metab. 2015 Jan;100(1): 19-20.
  • 2015A. Shifrin, V. LiVolsi, S. Shifrin-Douglas, M. Zheng, B. Erler, T. Matulewicz, J. Davis, Review Article “Primary and Metastatic Parathyroid Malignancies: A Rare or Underdiagnosed Condition?” J Clin Endocrinol Metab., 2015 Mar;100(3):E478-81
  • 2015E. Labourier, A. Shifrin, A. Busseniers, M. Lupo, M. Manganelli, B. Andruss, D. Wylie, S. Beaudenon-Huibregtse. “Molecular testing for miRNA, mRNA and DNA on fine needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology.” J Clin Endocrinol Metab., 2015 Jul;100(7):2743-50. Article
  • 2016L. Peddareddygari, P. Shah, A.Pahwa, A. Fay, A. Shifrin, and Raji Grewal "Positive Germline Selection in an Extended Pedigree with Multiple Endocrine Neoplasia Type 2 carrying V804M mutation in the RET gene". World Journal of Oncology. 7(5-6):104-108, December 2016
  • 2017Shifrin AL, Fischer M, Paul T, Erler B, Gheysens K, Baodhankar P, Song-Yang JW, Taylor S, Timmaraju VA, Topilow A, Mireskandari A, Kumar G. “Mutational analysis of metastatic lymph nodes from papillary thyroid carcinoma in adult and pediatric patients.” Surgery, Volume 161, Issue 1, January 2017, Pages 176–187. PDF
  • 2019J. Sistrunk, A. Shifrin, M. Frager, Bardales RH, Thomas J, Fishman N, Goldberg P, Guttler R, Grant E “Clinical impact of testing for mutations and microRNAs in thyroid nodules. Diagn Cytopathol., 2019, 47(8):758-764. Article
  • 2020Sistrunk JW, Shifrin A, Frager M, Bardales RH, Thomas J, Fishman N, Goldberg P, Guttler R, Grant E. Clinical performance of multiplatform mutation panel microRNA risk classifier in indeterminate thyroid nodules. J Am Soc Cytopathol. 2020 Jul-Aug;9(4):232-241.
  • 2020J. Sistrunk, A. Shifrin, M. Frager, R. Bardales, J. Thomas, N. Fishman, P. Goldberg, R. Guttler, E. Grant. SUN-LB24 Clinical Performance of Multiplatform Mutation Panel MicroRNA Risk Classifier in Indeterminate Thyroid Nodules. J Endocr Soc. 2020 May 8; 4(Suppl 1): SUN-LB24.

Letters to the editor (in peer-reviewed journals)

  • 2010Shifrin, AL., Xenachis, C., Fay, A., Matulewicz, T., Y.-H. Kuo, Vernick, JJ. The First Letter to the Editor: “One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: Is this a new syndrome-MEN 2C?” Surgery, 2010 Jun; 147(6):896-898. PDF
  • 2010Shifrin, AL, Xenachis, C, Fay, A, Vernick, JJ. The Second Letter to the Editor: “One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: Is this a new syndrome-MEN 2C?” Surgery, 2010 Sep;148(3):611-2. PDF
  • 2012A. Shifrin, A. Fay, J. Ogilvie, Y-H Kuo. Title: Response to "Single nucleotide polymorphisms and development of hereditary medullary thyroid cancer in V804M RET families: Disease modification or linkage disequilibrium?" Surgery, 2012 Jun;151(6):902-3 PDF

Video publication (peer-reviewed)

  • 2006Alexander Shifrin; William Inabnet; Joseph Grossman. Laparoscopic Left Adrenalectomy for Large 14 cm Pheochromocytoma. Cine-Med publication 2006, ACS-2526. The video shows the technique for a large left pheochromocytoma and gives technical pearls for large adrenal tumors. Cine-Med

Brochure for public education (national)

  • 2013Authored the patient education pamphlet “Pheochromocytoma: The Facts You Need to Know” for the National Adrenal Diseases Foundation (NADF). NADF

Abstracts

In peer-reviewed journals

  • 2000A. Auricchio, G.-P.Gao, P. Zoltick, A. Shifrin, S. Raper, and J. Wilson. "Regulated Insulin Gene Delivery for Treatment of Type 1 Diabetes" Abstract. Molecular Therapy, Vol 1, 5 (2): S293, 2000
  • 2000A. Shifrin, A. Auricchio, J. Wilson, and S. Raper. "Correction of Hyperglycemia by Adenoviral Vector-Mediated Insulin Gene Expression in the Murine Pancreas." Journal of the American College of Surgeons, October 2000, Vol. 191, Issue 4 (Supplement 1), Page S31
  • 2000A. Shifrin, A. Auricchio, J. Wilson, and S. Raper. "Correction of Hyperglycemia by Adenoviral Vector-Mediated Insulin Gene Expression in the Murine Pancreas." Abstract. Published in the Owen H. Wangensteen Surgical Forum, Vol. LI, 2000, 47-9
  • 2000A. Shifrin, N. Chirmule, K. Chapman, and S. Raper. "Innate Immune Response to Adenoviral Vector-Mediated Acute Pancreatitis," Abstract. J. of Surgical Research, 2000, Oct, Vol 93, 2: 359-360.
  • 2015J. Aguirre, L. Amorosa, A. Shifrin. “Aggressive Papillary Thyroid Carcinoma Associated With Prolong Graves’ Disease” Endocrine Practice, Vol 21, Supplement 2, May 2015, Abstract # 1034, pp 207-8.

Conference abstracts (local)

  • 1991A. Shifrin, S. Marchenko, and A. Bairov. "Follow-Up of Children Operated on for Nesidioblastosis." Presented at the Leningrad Surgical Conference and published in the Pathology Conference Journal, St. Petersburg, Russia, 1991.

Conference abstracts (national and international)

  • A. Auricchio, G.-P. Gao, V.Rivera, A. Shifrin, S.Raper, J. Wilson. "Regulated Insulin Gene Delivery for the Treatment of Type l Diabetes," 7th Annual Retreat, Institute for Human Gene Therapy, 1999.
  • A. Shifrin, N. Chirmule, K. Chapman, S. Raper "Innate Immune Response to Adenoviral Vector-Mediated Acute Pancreatitis", 34th Annual Meeting, Association for Academic Surgery, 11/2000
  • A. Shifrin, A. Auricchio, Q-C. Yu, J. Wilson, S. Raper. "Adenoviral vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemia." 62nd Annual Meeting, Society of University Surgeons, 2/2001
  • A. Shifrin, N. Chirmule, S. Raper, “Macrophage depletion diminishes acute pancreatic inflammation and immune responses in adenoviral vector induced pancreatitis,” 35th Annual Meeting of The Pancreas Club, Atlanta GA, 05/20/2001.
  • C. Menon, S. Kelly, G. Karakousis, K. Patel, S. Kesmodel, D. Raz, I. Prabakaran, A. Shifrin, D. Buerk and D. Fraker. “Tumor infiltration by macrophages and enhanced NO release are key to the tumoricidal activity of high-dose rhTNF-alpha in preclinical tumor models.” American Association for Cancer Research, 93rd Annual Meeting, 04/2002
  • A. Shifrin, C. LeClair, S. Raper. “Innate Immunity In The Pathogenesis Of Acute Viral Pancreatitis” 37th Annual Meeting, Pancreas Club. Chicago, IL 5/2003
  • A. Shifrin, M. Chinoy, P. Dillon. “Abnormal Development of the Hepatobiliary System in Nitrogen- Exposed Mice” 35th Annual Meeting, American Pediatric Surgical Association, Ft Lauderdale, FL 05/2004
  • A. Shifrin, W Inabnet, J. Grossman. “Laparoscopic left adrenalectomy for large 14 cm pheochromocytoma.” American College of Surgeons (ACS) Clinical Congress, Chicago, IL 2006
  • W. Inabnet, A. Shifrin, M. DiGorgi, J. Allendorf, J. Chabot. “Persistently elevated PTH levels during focused parathyroidectomy: do they predict failure or cure?” 27th Annual Meeting, American Association of Endocrine Surgeons (AAES), New York, NY, 5/2006.
  • AL Shifrin, C Xenachis, J.Vernick. “Incidence of papillary thyroid carcinoma increased in patients with Graves’ disease.” World Congress on Thyroid Cancer, Toronto, Canada, August 6-10, 2009
  • A. Shifrin, S. Asnani, J. Vernick. “Endocrine surgeon performed preoperative neck ultrasound changes or modified planed parathyroidectomy procedure in patients with primary hyperparathyroidism.” The Endocrine Society Annual Conference (ENDO 09), Washington DC, 6/2009
  • A. Shifrin, A. Fay, T. Matulewicz, C. Xenachis, J. Vernick, “Several single nucleotide polymorphisms may impact the development of medullary thyroid carcinoma in patients with the RET V804M proto-oncogene mutation” 8/2009
  • American Association of Endocrine Surgeons (AAES) 30th Annual Meeting, Madison, WI. “107 members of the family with RET V804M proto-oncogene mutation with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas. Is this a new syndrome -MEN 2C?” A. Shifrin, C. Xenachis, T. Matulewicz, A. Fay, Y. Kuo. J. Vernick 5/2009
  • ENDO 2009, The Endocrine Society 91st Annual Meeting. Washington, DC. “Endocrine surgeon performed preoperative neck ultrasound changes or modified planned parathyroidectomy procedure in patients with primary hyperparathyroidism.” A. Shifrin, S. Asnani, J. Vernick. 6/2009
  • The 14th International Thyroid Congress. Paris, France. “ Incidence of medullary thyroid carcinoma in the United States from 2001 TO 2007” A. Shifrin, Y.-H. Kuo, J. Davis. 09/2010
  • European Association of Endocrine Surgeons (ESES) Biennial Congress 2010, Vienna, Austria, “Complete Thyroidectomy on Graves ’ Disease: A Population-Based Analysis on 923 Patients in the United States” A. Shifrin, Y.-H. Kuo, Y.-L. Kuo, J. Vernick, J. Davis. 05/2010
  • American Association of Endocrine Surgeons (AAES). 31st Annual Meeting. Pittsburgh, PA. “Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in two large, non-related families with the RET V804M proto-oncogene mutation” A. Shifrin, J. Ogilvie, M. Shand, C. Xenachis, T. Matulewicz, A. Fay, Y. Kuo. J. Vernick 04/2010
  • American Thyroid Association (ATA), 82nd Annual Meeting, Quebec City, Canada. "BRAF Positive Thyroid Lymphoma: An Unusual Presentation and Clinical Dilemma " L. Jayakumar, D. Lann, M. Elsawaf, P. Mencel, S. Govil, and A. Shifrin. 19/9/2012
  • American Thyroid Association (ATA), 82nd Annual Meeting, Quebec City, Canada. "Initial modes of detection of thyroid nodules in surgical patients in correlation to family history, radiation exposure, and final pathological diagnosis " J. Anderson, D. Lann, S. Asnani, Y.-H. Kuo, and A. Shifrin. 20/9/2012 -
  • American Thyroid Association (ATA), 82nd Annual Meeting, Quebec City, Canada. "Graves’ Disease In Pregnancy Presenting with Fetal Goiter " J. Fischetti-Galvin, J. Canterino, C. Leo, LaToya Walker, D. Lann, L. Van Horn, A. Shifrin. 21/9/2012
  • American Society of Clinical Oncology (ASCO) 2012 Annual Meeting, Chicago, IL “MEN1 gene mutations with different phenotypic presentations in two families: Is it a time to grade MEN1 mutations as high-risk and low-risk?” A. Shifrin, A. Bale, D. Dykas, A.M. Fay, K. Belitsis, S. Fomin, D. Lann, R. Villanueva, M. Zheng, S. Govil, B. Erler, T. Matulewicz, A. Topilow, M. Krasna, J. Vernick 6/2/2012
  • American Association of Endocrine Surgeons (AAES). 33rd Annual Meeting. Iowa City, Iowa. “Use of Molecular Markers on FNA Biopsies of Thyroid Nodules, as Recommended by Recent ATA Guideline, Modifies Surgical Treatment of Thyroid Nodules and Thyroid Cancer.” A. Shifrin, C. Huang, D. Lann, S. Asnani. 5/1/12
  • American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress in Philadelphia, PA, May 23-27, 2012. “Novel Gene Expression Classifier Raises Pre- Operative Suspicion OF Medullary Thyroid Cancer” Authors: R. Kloos, K. O’Reilly, S. T. Traweek, E. Alexander, R. M. Harrell, B. Haugen, E. Khanafshar, J. Klopper, J. Koval, R. Kulstad, S. Reddy, A. Shifrin, D. Steward, D. Chudova, L. Friedman, R.Monroe, N. Sindy, G. Kennedy, R. Lanman. 5/2012
  • American Association of Clinical Endocrinologists (AACE), 21st Annual Scientific and Clinical Congress in Philadelphia, PA. “A Rare Case OF Amiodarone Induced Thyrotoxicosis and Thionamide Agranulocytosis” S. Dhillon, F. Cruz, D. Lann, and A. Shifrin. 5/2012
  • The 2nd World Congress on Thyroid Cancer. Toronto, Canada “Assessment of Molecular Markers on Preoperative FNA Biopsies of Metastatic Lymph Nodes from Differentiated Thyroid Carcinoma and Correlation with the Primary Thyroid Tumor: the feasibility study” A. Shifrin, D. Lann, T. Matulewicz, B. Erler, M. Zheng6/28/13
  • American Association of Endocrine Surgeons (AAES). 34th Annual Meeting, Chicago, IL. “Patients With Family History Of Thyroid Carcinomas In The Second Degree Family Members Have Carried The Same Risk For Development Of Thyroid Carcinoma As In The First Degree Members.” A. Shifrin, J. Anderson, D. Lann, S. Asnani, Y.-H. Kuo. 4/14/13
  • American Association of Endocrine Surgeons (AAES). 34th Annual Meeting, Chicago, IL. “Neuroendocrine Carcinoma Metastatic To The Parathyroid Gland That Was Re-Implanted Into The Forearm In Patient With Multiple Endocrine Neoplasia Type 1 Syndrome: A challenging Management Dilemma”. A. Shifrin, V. LiVolsi, A. Fay, D. Lann, M. Zheng, B. Erler, T. Matulewicz, S. Fomin, E. Naylor, P. Mencel. 4/14/13
  • American Association of Clinical Endocrinologists (AACE) 24th Annual Scientific and Clinical Congress in Nashville, TN, May 13-17, 2015 LATE GROUNDBREAKING ABSTRACT “Primary Hyperparathyroidism in Teenagers and Young Adults has More Dramatic Initial Presentation With an Emergency Room Admission Due to a Very High Hypercalcemia and Also Diagnosed in Advanced Stage” M. Fischer, S. Eapen, M. Smotkin-Tangorra, B. Erler, M. Zheng, and A. Shifrin. 5/2015
  • American Association of Clinical Endocrinologists (AACE) 24th Annual Scientific and Clinical Congress in Nashville, TN, May 13-17, 2015 “Aggressive Papillary Thyroid Carcinoma Associated With Prolonged Graves’ Disease” 5/2015
  • The American Association of Endocrine Surgeons (AAES) 2016 37th Annual Meeting. Alexander Shifrin, Michele Fischer, Trevor Paul, Brian Erler, Katherine Gheysens, Prachi Baodhankar, Joanna W. Song-Yang, Samantha Taylor, Venkata Arun Timmaraju, Alidad Mireskandari, and Gyanendra Kumar. “Prognostic assessment of recurrence and radioactive iodine (RAI) resistance in adult and pediatric patients using mutational analysis of metastatic lymph nodes from differentiated thyroid carcinomas” 3/2016
  • The American Association of Endocrine Surgeons (AAES) 2016 37th Annual Meeting. “Pediatric and young adult patients with sporadic thyroid nodules have a very high rate of malignancy and presented with more advanced disease and a high prevalence of lymph nodes metastases.” Michele Fischer, Santosh Eapen, Margarita Smotkin-Tangorra, Brian Erler, Min Zheng, and Alexander Shifrin. 3/2016

Book

Cover of Wellness Protection Program: The Thyroid Cancer Survivor Story and Recovery Protocol

Wellness Protection Program: The Thyroid Cancer Survivor Story and Recovery Protocol

by Katie Napoli, MA, and Alexander Shifrin, MD. 215 pages, June 23, 2025. ISBN-13: 979-8288136207.

Katie, a thyroid cancer survivor, shares her journey of resilience and healing. With Dr. Shifrin, she describes a Wellness Protection Program for life after treatment: nutrition, lifestyle, mental health, spiritual care, physical recovery and ongoing education.

See the book on Amazon →

Reference of my work in national and international guidelines and literature

Reference of Dr. Shifrin's work in national and international guidelines, image 1Reference of Dr. Shifrin's work in national and international guidelines, image 2Reference of Dr. Shifrin's work in national and international guidelines, image 3Reference of Dr. Shifrin's work in national and international guidelines, image 4Reference of Dr. Shifrin's work in national and international guidelines, image 5

Related

Make an appointment. Call (732) 792-5003 or request a consultation online. Offices in Englishtown and Toms River, NJ. Surgery at Atlantic Health CentraState Medical Center, Freehold, NJ.

Call (732) 792-5003 Request a consultation